Panel: Funding the Next Medical Breakthrough
Michael Straightiff, Director at U.Va. Licensing & Ventures Group
| As Part of: | Panel: Funding the Next Medical Breakthrough | |
| Date: | ||
| Time: | ||
| Price: | Free | |
| Location: | The Haven | |
| Partner Website: | Click Here |
Michael P. Straightiff joined the University of Virginia Licensing & Ventures Group as director in September 2011.
Previously, as director of biomedical engineering commercialization in Case Western Reserve University's Technology Transfer Office, Straightiff managed high-profile research, development and commercialization partnerships with several large biomedical technology companies. He was also involved in the formation of companies spun out of Case, in coordination with Case Technology Ventures and the local investment community. Straightiff served on the board of directors for a venture-backed neurostimulation company and an early-stage biomedical imaging company. At Case, Straightiff also served on the institutional oversight committee for the school's Wallace H. Coulter Translational Research Partnership.
Straightiff formerly was a senior licensing associate and a consultant for Virginia Tech Intellectual Properties Inc., where he managed a diverse portfolio of technologies in engineering, physical sciences and life sciences. He also worked as a patent examiner for the U.S. Patent and Trademark Office after serving as research assistant at the Cleveland Functional Electrical Stimulation Center.
